Not all patients with CLL need therapy. Even with all the latest innovations, the iwCLL still endorses watchful observation for clients with asymptomatic disorder.86 This suggestion relies on a minimum of two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Eq